<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27849298</article-id><article-id pub-id-type="pmc">5094415</article-id><article-id pub-id-type="doi">10.5935/1678-9741.20160060</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Long-term Mortality Predictors in Patients with Small Aortic Annulus
Undergoing Aortic Valve Replacement with a 19- or 21-mm Bioprosthesis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>de Oliveira</surname><given-names>Jenny Lourdes Rivas</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Arnoni</surname><given-names>Renato Tambellini</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>dos Santos</surname><given-names>Magaly Arrais</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Almeida</surname><given-names>Antonio Fl&#x000e1;vio Sanchez</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Issa</surname><given-names>M&#x000e1;rio</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Arnoni</surname><given-names>Antoninho Sanfins</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Chaccur</surname><given-names>Paulo</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>de Souza</surname><given-names>Luiz Carlos Bento</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><aff id="aff1"><label>1</label> Instituto Dante Pazzanese de Cardiologia, S&#x000e3;o Paulo, SP, Brazil.
</aff></contrib-group><author-notes><corresp id="c1"><bold>Correspondence Address:</bold> Jenny Lourdes Rivas de Oliveira,
Instituto Dante Pazzanese de Cardiologia, Av. Dr. Dante Pazzanese, 500 &#x02013; Vila Mariana,
S&#x000e3;o Paulo, SP, Brazil &#x02013; Zip code: 04012-909, E-mail:
<email>jennyr16@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Jul-Sep</season><year>2016</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Jul-Sep</season><year>2016</year></pub-date><volume>31</volume><issue>4</issue><fpage>275</fpage><lpage>280</lpage><history><date date-type="received"><day>10</day><month>5</month><year>2016</year></date><date date-type="accepted"><day>30</day><month>5</month><year>2016</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Introduction</title><p>Replacement of the aortic valve in patients with a small aortic annulus is associated
with increased morbidity and mortality. A prosthesis-patient mismatch is one of the main
problems associated with failed valves in this patient population.</p></sec><sec><title>Objective</title><p>To evaluate the long-term mortality predictors in patients with a small aortic annulus
undergoing aortic valve replacement with a bioprosthesis.</p></sec><sec><title>Methods</title><p>In this retrospective observational study, a total of 101 patients undergoing aortic
valve replacement from January 2000 to December 2010 were studied. There were 81
(80.19%) women with a mean age of 52.81&#x000b1;18.4 years. Severe aortic stenosis was
the main indication for surgery in 54 (53.4%) patients. Posterior annulus enlargement
was performed in 16 (15.8%) patients. Overall, 54 (53.41%) patients underwent
concomitant surgery: 28 (27.5%) underwent mitral valve replacement, and 13 (12.7%)
underwent coronary artery bypass graft surgery.</p></sec><sec><title>Results</title><p>Mean valve index was 0.82&#x000b1;0.08 cm<sup>2</sup>/m<sup>2</sup>. Overall, 17
(16.83%) patients had a valve index lower than 0.75 cm<sup>2</sup>/m<sup>2</sup>,
without statistical significance for mortality (<italic>P</italic>=0.12). The overall
10-year survival rate was 83.17%. The rate for patients who underwent isolated aortic
valve replacement was 91.3% and 73.1% (<italic>P</italic>=0.02) for patients who
underwent concomitant surgery. In the univariate analysis, the main predictors of
mortality were preoperative ejection fraction (<italic>P</italic>=0.02; HR 0.01) and
EuroSCORE II results (<italic>P</italic>=0.00000042; HR 1.13). In the multivariate
analysis, the main predictors of mortality were age (<italic>P</italic>=0.01, HR 1.04)
and concomitant surgery (<italic>P</italic>=0.01, HR 5.04). Those relationships were
statistically significant.</p></sec><sec><title>Conclusion</title><p>A valve index of &#x0003c; 0.75 cm<sup>2</sup>/m<sup>2</sup> did not affect 10-year
survival. However, concomitant surgery and age significantly affected mortality.</p></sec></abstract><kwd-group><kwd>Aortic Valve Stenosis</kwd><kwd>Heart Valve Prosthesis Implantation</kwd><kwd>Bioprosthesis</kwd><kwd>Mortality</kwd></kwd-group></article-meta></front><body><table-wrap id="t4" orientation="portrait" position="anchor"><table frame="hsides" rules="groups" style="background-color:#e6e7e8"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Abbreviations, acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">CABG</td><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;= Coronary artery bypass graft</td></tr><tr><td align="left" rowspan="1" colspan="1">CI</td><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;= Confidence interval</td></tr><tr><td align="left" rowspan="1" colspan="1">CPB</td><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;= Cardiopulmonary bypass</td></tr><tr><td align="left" rowspan="1" colspan="1">EF</td><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;= Ejection fraction</td></tr><tr><td align="left" rowspan="1" colspan="1">LVEF</td><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;= Left ventricular ejection
fraction</td></tr><tr><td align="left" rowspan="1" colspan="1">NYHA</td><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;= New York Heart Association</td></tr><tr><td align="left" rowspan="1" colspan="1">PPM</td><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;= Prosthesis-patient mismatch</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Prosthetic aortic valve replacement is a therapeutic option for patients with symptomatic
aortic valve disease. Patients with aortic stenosis benefit from aortic valve replacement
because this procedure reduces left ventricular afterload, which leads to a significant
reduction in left ventricular muscle hypertrophy and marked clinical improvement<sup>[<xref rid="B1" ref-type="bibr">1</xref>]</sup>.</p><p>In the late 1970s, Rahimtoola<sup>[<xref rid="B2" ref-type="bibr">2</xref>]</sup> suggested
that the main complications from valve replacement surgery were thromboembolism, bleeding
from anticoagulation therapy, prosthetic dysfunction, the need for valve re-replacement, and
prosthesis-patient mismatch (PPM). Additionally, complications arise when the effective
orifice area of the implanted prosthesis is considered small in relation to the patient's
body surface. This condition leads to severe hemodynamic disorders in patients, thereby
triggering the exchange of one disease for another<sup>[<xref rid="B2" ref-type="bibr">2</xref>]</sup>.</p><p>Small aortic annulus is associated with increased operative mortality due to PPM, which
results in significantly increased mortality in the short- and long-term<sup>[<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B4" ref-type="bibr">4</xref>]</sup>.</p><p>Aortic valve replacement candidates most likely to suffer from PPM are generally elderly
patients with a small aortic root diameter or patients with left ventricular
hypertrophy<sup>[<xref rid="B5" ref-type="bibr">5</xref>]</sup>. In addition, obesity is
associated with increased late mortality and a poor quality of life in patients with a small
aortic valve who undergo prosthetic valve replacement<sup>[<xref rid="B6" ref-type="bibr">6</xref>]</sup>.</p><p>Enlargement of the aortic annulus is a surgical option to reduce the risk of PPM and late
mortality. However, several studies have shown that this procedure is associated with a
significant increase in surgical risk<sup>[<xref rid="B7" ref-type="bibr">7</xref>]</sup>.</p><p>Calculating the valve index is recommended when selecting the size and type of prosthesis
that will provide an adequate effective orifice for the patient's body surface. Studies have
shown that for patients with a body surface area of less than 1.7 m<sup>2</sup>, it is safe
to use a prosthesis smaller or equal to 21 mm<sup>[<xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B8" ref-type="bibr">8</xref>,<xref rid="B9" ref-type="bibr">9</xref>]</sup>. However, studies suggest that the use of prostheses smaller than the
recommended size does not result in higher residual gradients<sup>[<xref rid="B10" ref-type="bibr">10</xref>]</sup>.</p><p>Concomitant coronary artery bypass graft surgery (CABG) and advanced age are risk factors
that affect the long-term survival of patients undergoing aortic valve replacement, and the
risk increases when PPM occurs<sup>[<xref rid="B11" ref-type="bibr">11</xref>]</sup>.</p><p>The aim of the present study was to evaluate the long-term mortality predictors in patients
with a small aortic annulus undergoing aortic valve replacement with a 19- or 21-mm
bioprosthesis.</p></sec><sec sec-type="methods"><title>METHODS</title><p>Between January 2000 and December 2010, a total of 1,559 prostheses were implanted in the
aortic valve position. Of those, 165 were biological and either 19 or 21 mm in size. A total
of 101 patients who underwent implantation of a 19- or 21-mm bioprosthesis with or without
enlargement of the aortic annulus and who had complete medical records were included in this
study.</p><p>Mean age of the patients was 52.81&#x000b1;18.4 years (12-81 years old, median 57 years
old). A total of 81 (80.19%) patients were women, and most patients (81-80.1%) were
classified as New York Heart Association (NYHA) functional class II or III. Surgery was
indicated for significant stenosis in 54 (53.41%) patients, double aortic lesions in 27
(26.5%), and bioprosthetic dysfunction in 8 (7.8%). Overall, 3 patients were excluded
because they were younger than 12 years of age. Mean follow-up time was 8.16 years (95% CI
7.40-8.93 years), with a maximum of 10 years.</p><p>The findings in the relevant preoperative echocardiograms were left ventricular ejection
fraction (LVEF), mean 65.36&#x000b1;9.2% (27%-87%, median 66%); transvalvular aortic systolic
gradient, mean 49.10&#x000b1;0.54 mmHg (4-104 mmHg, median 47 mmHg); left atrium &#x0003e;40 mm in
77 (76.23%) patients; moderate or severe pulmonary hypertension in 30 (29.70%) patients; and
moderate or severe left ventricular hypertrophy in 34 (33.66%) patients. The mean EuroSCORE
II finding was 5.15&#x000b1;4.35% (0.71%-35.50%, median 3.86%). EuroSCORE II was used to
calculate risk instead of the EuroSCORE because its model is more updated, with better
calibration and discrimination, especially for patients undergoing aortic valve replacement
with concomitant procedures<sup>[<xref rid="B12" ref-type="bibr">12</xref>]</sup>. The
demographics and clinical characteristics of the patients are reported in <xref ref-type="table" rid="t1">Table 1</xref>.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Preoperative clinical characteristics of the patients.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="33%" span="1"/><col width="33%" span="1"/><col width="33%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">Total population n=101</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, years</td><td align="center" rowspan="1" colspan="1">52.81&#x000b1;18.4</td><td align="center" rowspan="1" colspan="1">0.017</td></tr><tr><td align="left" rowspan="1" colspan="1">Body surface area, m<sup>2</sup></td><td align="center" rowspan="1" colspan="1">1.59&#x000b1;0.15</td><td align="center" rowspan="1" colspan="1">0.20</td></tr><tr><td align="left" rowspan="1" colspan="1">EuroSCORE II</td><td align="center" rowspan="1" colspan="1">5.15&#x000b1;4.35%</td><td align="center" rowspan="1" colspan="1">0.00000042</td></tr><tr><td align="left" rowspan="1" colspan="1">SAH</td><td align="center" rowspan="1" colspan="1">57 (56.43%)</td><td align="center" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">DM</td><td align="center" rowspan="1" colspan="1">19 (18.81%)</td><td align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">Dyslipidemia</td><td align="center" rowspan="1" colspan="1">31 (30.69%)</td><td align="center" rowspan="1" colspan="1">0.15</td></tr><tr><td align="left" rowspan="1" colspan="1">Peripheral arterial disease</td><td align="center" rowspan="1" colspan="1">6 (5.94%)</td><td align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">Kidney failure</td><td align="center" rowspan="1" colspan="1">5 (4.95%)</td><td align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">COPD</td><td align="center" rowspan="1" colspan="1">8 (7.92%)</td><td align="center" rowspan="1" colspan="1">0.69</td></tr><tr><td align="left" rowspan="1" colspan="1">Current smoker</td><td align="center" rowspan="1" colspan="1">17 (16.83%)</td><td align="center" rowspan="1" colspan="1">0.49</td></tr><tr><td align="left" rowspan="1" colspan="1">Rheumatic fever</td><td align="center" rowspan="1" colspan="1">30 (29.70%)</td><td align="center" rowspan="1" colspan="1">0.19</td></tr><tr><td align="left" rowspan="1" colspan="1">Prior heart surgery</td><td align="center" rowspan="1" colspan="1">30 (29.70%)</td><td align="center" rowspan="1" colspan="1">0.68</td></tr><tr><td align="left" rowspan="1" colspan="1">Obesity</td><td align="center" rowspan="1" colspan="1">9 (8.91%)</td><td align="center" rowspan="1" colspan="1">0.12</td></tr><tr><td align="left" rowspan="1" colspan="1">NYHA II-III</td><td align="center" rowspan="1" colspan="1">81 (80.19%)</td><td align="center" rowspan="1" colspan="1">0.26</td></tr><tr><td align="left" rowspan="1" colspan="1">Ejection fraction &#x0003c; 60%</td><td align="center" rowspan="1" colspan="1">14 (13.86%)</td><td align="center" rowspan="1" colspan="1">0.02</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>SAH=systemic arterial hypertension; DM=diabetes mellitus; COPD=chronic obstructive
pulmonary disease; NYHA=New York Heart Association</p></fn></table-wrap-foot></table-wrap><p>Implantation of the 19- and 21-mm biological valve prostheses in the aortic position was
performed using median sternotomy with extracorporeal circulation and moderate hypothermia
of 30&#x000b0;C-32&#x000b0;C. Myocardial protection was achieved with crystalloid cardioplegia or
hypothermic antegrade blood in the aortic root or directly in the coronary ostia depending
on the competence of the aortic valve. In 16 (15.84%) patients, posterior enlargement of the
aortic annulus was performed (Manouguian technique)<sup>[<xref rid="B13" ref-type="bibr">13</xref>]</sup>. The following types of bioprostheses were used: Biocor bovine
pericardium in 78 patients, Biocor Epic in 15, Labcor in 4, and Braile in 2. A 21-mm
prosthesis was used in 99 patients and a 19-mm prosthesis was used in 2 (Biocor bovine
pericardium).</p><p>The valve index was calculated for all patients by dividing the internal area of the
prosthesis by the body surface. An index below 0.75 cm<sup>2</sup>/m<sup>2</sup> was
indicative of a risk of PPM<sup>[<xref rid="B2" ref-type="bibr">2</xref>]</sup>.</p><p>The data were collected retrospectively from clinical, surgical, and preoperative
complementary tests and postoperative records. The analysis included 30-day and long-term
postoperative evaluations of mortality and adverse events related to the surgical
procedures.</p><p>The valve index in the deceased and non-deceased patients was evaluated. In addition, the
final mean transvalvular aortic gradient relative to the valve index and survival for
isolated aortic valve replacement and concomitant procedures were assessed.</p><p>The data are presented as frequency distribution and simple percentages. Continuous
variables are expressed as mean &#x000b1; standard deviation, and median when indicated.
Categorical variables are expressed as absolute and relative frequencies. For the survival
analysis and mortality predictors, we used the Kaplan-Meier curve method (with the log-rank
test), Cox regression model, and the Mann-Whitney test. The variables that were significant
in the univariate analysis or associated with clinical relevance were subsequently adjusted
in the Cox multivariate analysis. The 95% confidence intervals (CIs) were calculated.
<italic>P</italic>&#x0003c;0.05 was considered statistically significant.</p></sec><sec sec-type="results"><title>RESULTS</title><p>Aortic valve replacement with a 19- or 21-mm bioprosthesis was performed without annulus
enlargement in 85 (84.15%) patients and with aortic annulus enlargement using the Manouguian
technique in 16 (15.84%) patients. Of those patients, 54 (53.46%) underwent concomitant
surgery, including mitral valve replacement in 28 (27.50%) patients and myocardial
revascularization in 13 (12.70%). Mean anoxia time was 80.52&#x000b1;7.15 minutes (36-160
minutes, median 76 minutes), and mean cardiopulmonary bypass (CPB) time was
114.44&#x000b1;48.19 minutes (45-325 minutes, median 100 minutes).</p><p>Mean valve index was 0.82&#x000b1;0.08 cm<sup>2</sup>/m<sup>2</sup> (0.65-1.18
cm<sup>2</sup>/m<sup>2</sup>, median 0.83 cm<sup>2</sup>/m<sup>2</sup>), and 17 (16.83%)
patients had a valve index lower than 0.75 cm<sup>2</sup>/m2 (<italic>P</italic>=0.12).</p><p>No differences were found between the valve indices in the deceased and non-deceased
patients. The mean valve index for the deceased patients was 0.81&#x000b1;0.006
cm<sup>2</sup>/m<sup>2</sup> (0.76-0.85 cm<sup>2</sup>/m<sup>2</sup>, median 0.80
cm<sup>2</sup>/m<sup>2</sup>) and the mean index for the non-deceased patients was 0.82
cm<sup>2</sup>/m<sup>2</sup>&#x000b1;0.007 (0.81-0.84 cm<sup>2</sup>/m<sup>2</sup>, median
0.82 cm<sup>2</sup>/m<sup>2</sup>) (P=0.33) (<xref ref-type="fig" rid="f1">Figure
1</xref>).</p><p><fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Valve index and mortality.</p></caption><graphic xlink:href="rbccv-31-04-0275-g01"/></fig>
</p><p>Mean preoperative aortic transvalvular gradient was 49.10&#x000b1;20.54 mmHg (4-104 mmHg,
median 47.00 mmHg). In the early postoperative period, the mean gradient was
20.54&#x000b1;7.55 mmHg (5-42 mmHg, median 20.00 mmHg), and the long-term mean gradient was
26.11&#x000b1;12.72 mmHg (5-64 mmHg, median 23 mmHg). Overall, 1 (0.99%) patient had a mean
aortic transvalvular gradient greater than 40 mmHg after aortic valve replacement and a
valve index of 0.72 cm<sup>2</sup>/m<sup>2</sup>, which suggests a PPM. A lower valve index
was associated with a higher mean postoperative aortic transvalvular gradient. However, this
finding was not significant (<italic>P</italic>=0.20).</p><p>In the long-term analysis, when the valve index was &#x0003c; 0.75 cm<sup>2</sup>, the final
mean aortic transvalvular valve gradient was 28.64&#x000b1;12.40 mmHg (13-53 mmHg, median 28
mmHg). When the valve index was &#x0003e;0.75 cm<sup>2</sup>, the mean gradient was
25.71&#x000b1;12.80 mmHg (5-64 mmHg, median 23 mmHg); however, this finding was not
significant (<italic>P</italic>=0.43) (<xref ref-type="fig" rid="f2">Figure 2</xref>). The
30-day postoperative results are reported in <xref ref-type="table" rid="t2">Table
2</xref>.</p><p><fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Valve index and final mean systolic gradient.</p></caption><graphic xlink:href="rbccv-31-04-0275-g02"/></fig>
</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Postoperative results at 30 days.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">Total population <break/>n=101</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Inotropic support</td><td align="center" rowspan="1" colspan="1">14 (13.86%)</td></tr><tr><td align="left" rowspan="1" colspan="1">IABP</td><td align="center" rowspan="1" colspan="1">5 (4.95%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Reoperation for bleeding</td><td align="center" rowspan="1" colspan="1">5 (4.95%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Respiratory complications</td><td align="center" rowspan="1" colspan="1">10 (9.90%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Stroke</td><td align="center" rowspan="1" colspan="1">4 (3.96%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Permanent pacemaker</td><td align="center" rowspan="1" colspan="1">1 (0.99%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Hospitalization time</td><td align="center" rowspan="1" colspan="1">9.0&#x000b1;5.0 days</td></tr><tr><td align="left" rowspan="1" colspan="1">30-day mortality</td><td align="center" rowspan="1" colspan="1">15 (14.85%)</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>IABP=intra-aortic balloon pump</p></fn></table-wrap-foot></table-wrap><p>A total of 27 patients had complications during hospitalization; 8 (7.92%) patients had
pneumonia, and 4 (3.96%) had atrial fibrillation with a rapid ventricular response.</p><p>The overall 10-year survival rate was 83.17% (<xref ref-type="fig" rid="f3">Figure
3</xref>). The 10-year survival rate for patients who underwent isolated aortic valve
replacement was 91.3%, and the rate for patients who underwent concomitant surgery was 73.1%
(<italic>P</italic>=0.02). The difference in survival rates was detected during the first
6 months of follow-up because 15 of the 17 patient deaths occurred in the first 30 days
(<xref ref-type="fig" rid="f4">Figure 4</xref>).</p><p><fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Kaplan-Meier survival curve of patients undergoing aortic valve replacement with a
bioprosthesis (19 and 21 mm).</p></caption><graphic xlink:href="rbccv-31-04-0275-g03"/></fig>
</p><p><fig id="f4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Survival curve of patients undergoing aortic valve replacement with and without
concomitant surgery.</p></caption><graphic xlink:href="rbccv-31-04-0275-g04"/></fig>
</p><p>In the univariate analysis, the main mortality predictors were preoperative ejection
fraction (EF) (<italic>P</italic>=0.02; HR 0.01, 95% CI 0.0002-0.53) and EuroSCORE II
results (<italic>P</italic>=0.00000042; HR 1.13, 95% CI 1.08-1.19).</p><p>NYHA functional class (<italic>P</italic>=0.19; HR 1.87, 95% CI 0.72-4.82) and reoperation
(<italic>P</italic>=0.67, HR 1.23, 95% CI 0.46-3.28) were not statistically
significant.</p><p>In the multivariate analysis, when age, valve index, concomitant surgery, and EF were
analyzed simultaneously, only age (<italic>P</italic>=0.01, HR 1.04, 95% CI 1.009-1.08) and
concomitant surgery (<italic>P</italic>=0.01; HR 5.04, 95% CI 1.41-18.02) were significant
predictors of mortality (<xref ref-type="table" rid="t3">Table 3</xref>).</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Multivariate analysis.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Variables</th><th align="center" rowspan="2" colspan="1"><italic>P</italic> value</th><th align="center" rowspan="2" colspan="1">HR</th><th align="center" colspan="2" rowspan="1">CI 95.0% for HR</th></tr><tr><th align="center" rowspan="1" colspan="1">Minimum</th><th align="center" rowspan="1" colspan="1">Maximum</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">0.014</td><td align="center" rowspan="1" colspan="1">1.046</td><td align="center" rowspan="1" colspan="1">1.009</td><td align="center" rowspan="1" colspan="1">1.083</td></tr><tr><td align="left" rowspan="1" colspan="1">Valve index</td><td align="center" rowspan="1" colspan="1">0.152</td><td align="center" rowspan="1" colspan="1">0.459</td><td align="center" rowspan="1" colspan="1">0.158</td><td align="center" rowspan="1" colspan="1">1.331</td></tr><tr><td align="left" rowspan="1" colspan="1">Additional surgery</td><td align="center" rowspan="1" colspan="1">0.013</td><td align="center" rowspan="1" colspan="1">5.046</td><td align="center" rowspan="1" colspan="1">1.412</td><td align="center" rowspan="1" colspan="1">18.026</td></tr><tr><td align="left" rowspan="1" colspan="1">EF</td><td align="center" rowspan="1" colspan="1">0.079</td><td align="center" rowspan="1" colspan="1">0.016</td><td align="center" rowspan="1" colspan="1">0.000</td><td align="center" rowspan="1" colspan="1">1.608</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p>EF=ejection fraction; HR=Hazard Ratio</p></fn></table-wrap-foot></table-wrap><p>During 10 years of follow-up, 14 patients required aortic valve re-replacement. Of those,
re-replacement was indicated for bioprosthesis dysfunction in 10 (71.42%) patients,
endocarditis in 3 (21.42%) patients, and PPM in 1 (7.14%). After 4 years of follow-up, 98%
of the patients did not require aortic valve rereplacement. After 5 years of follow-up,
95.3% of the patients did not require aortic valve re-replacement, and after 10 years, 58.8%
of the patients did not require valve re-replacement (<xref ref-type="fig" rid="f5">Figure
5</xref>).</p><p><fig id="f5" orientation="portrait" position="float"><label>Fig. 5</label><caption><p>Kaplan-Meier curve shows the time until aortic valve rereplacement was needed.</p></caption><graphic xlink:href="rbccv-31-04-0275-g05"/></fig>
</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>A small aortic annulus is predominantly found in female and elderly patients; therefore,
comorbidities and increased risks are associated with these patient populations<sup>[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B8" ref-type="bibr">8</xref>,<xref rid="B14" ref-type="bibr">14</xref>-<xref rid="B16" ref-type="bibr">16</xref>]</sup>.</p><p>Bahlmann et al.<sup>[<xref rid="B17" ref-type="bibr">17</xref>]</sup> evaluated a total of
1,563 patients with mild to moderate aortic stenosis and found a small aortic annulus in 32%
of the patients, which was twice as frequently found in women (<italic>P</italic>&#x0003c;0.05).
A small aortic annulus is an independent predictor of mortality in patients with aortic
stenosis<sup>[<xref rid="B17" ref-type="bibr">17</xref>]</sup>.</p><p>In our study, 80.19% of the patients were women. However, the mean age of our patients was
52.81&#x000b1;18.4 years, which is lower than the mean age found in other studies<sup>[<xref rid="B14" ref-type="bibr">14</xref>,<xref rid="B15" ref-type="bibr">15</xref>]</sup>.</p><p>Previous studies have shown a low frequency of patients with severe PPM and a valve index
lower than 0.65 cm<sup>2</sup>/m<sup>2</sup><sup>[<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B16" ref-type="bibr">16</xref>,<xref rid="B18" ref-type="bibr">18</xref>,<xref rid="B19" ref-type="bibr">19</xref>]</sup>. In the present study, only
17 (16.83%) patients had a valve index lower than 0.75 cm<sup>2</sup>/m<sup>2</sup>, and
only 1 (0.99%) patient had severe PPM requiring aortic valve re-replacement.</p><p>In studies that evaluated the impact of concomitant surgeries on outcomes of aortic valve
replacement, CABG was the most common concomitant procedure<sup>[<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B18" ref-type="bibr">18</xref>,<xref rid="B20" ref-type="bibr">20</xref>,<xref rid="B21" ref-type="bibr">21</xref>]</sup>. In our study, the
most common concomitant procedures were mitral valve replacement (27.5% of patients) and
myocardial revascularization (12.7% of patients).</p><p>A study of 148 patients who underwent isolated aortic valve replacement with a 19- or 21-mm
bioprosthesis revealed a 30- day mortality rate of 6.1%<sup>[<xref rid="B14" ref-type="bibr">14</xref>]</sup>. Another study of 68 patients who received an 18- or 20-mm Sorin
Soprano prosthetic implant showed a 30-day mortality of 4.4%<sup>[<xref rid="B22" ref-type="bibr">22</xref>]</sup>. In a series of 53 patients undergoing aortic valve
replacement plus annulus expansion with implantation of a 19-, 21-, or 23-mm prosthesis, the
30-day mortality rate was 2%<sup>[<xref rid="B23" ref-type="bibr">23</xref>]</sup>. Another
study found that the 30-day mortality rate was 4.3% in patients who received implanted
prostheses smaller than 22 mm<sup>[<xref rid="B7" ref-type="bibr">7</xref>]</sup>.</p><p>In a study of 41 patients who received either a stentless aortic prosthesis or a
conventional prosthesis with or without CABG, Rao et al.<sup>[<xref rid="B20" ref-type="bibr">20</xref>]</sup> obtained a mortality rate of 0% in patients with a stentless
prosthesis <italic>versus</italic> 6% in patients with a conventional prosthesis.</p><p>Another study that evaluated mechanical prosthetic valves implanted in the aortic position
found an in-hospital mortality rate of 3.9%<sup>[<xref rid="B24" ref-type="bibr">24</xref>]</sup>. In a study of 11 female patients who received 17-mm Regent St. Jude
metallic prostheses, Takaseya et al.<sup>[<xref rid="B19" ref-type="bibr">19</xref>]</sup>
observed a 0% mortality rate.</p><p>Our 30-day mortality rate for isolated aortic valve replacement (1.98%) is lower than those
in other studies. This finding is most likely because the mean age of our population was
lower and their etiology was usually rheumatic. However, the mortality rate increased to
12.87% (<italic>P</italic> =0.02) in patients who underwent concomitant surgery because this
patient group is at a higher risk of mortality due to longer operative and CPB times.</p><p>In a retrospective study of elderly patients undergoing aortic valve replacement, Tagliari
et al.<sup>[<xref rid="B25" ref-type="bibr">25</xref>]</sup> found an in-hospital mortality
rate of 9.4% in the isolated aortic stenosis surgery group <italic>versus</italic> 20.9% in
patients who underwent another surgical procedure. The main mortality predictors were
ischemia time &#x0003e; 90 minutes, EF &#x0003c; 60%, and prior stroke.</p><p>Regarding long-term survival rates following aortic valve replacement, a study of high-risk
patients<sup>[<xref rid="B14" ref-type="bibr">14</xref>]</sup> found a 10-year survival
rate of 40.9%. Celiento et al.<sup>[<xref rid="B23" ref-type="bibr">23</xref>]</sup> found a
10-year survival rate of 68&#x000b1;7% in patients who underwent valve replacement with
aortic annulus enlargement.</p><p>In our study, the 10-year survival rate was 83.17%. This finding was comparable with the
results obtained by Walther et al.<sup>[<xref rid="B18" ref-type="bibr">18</xref>]</sup> who
observed a survival rate of 79.6&#x000b1;1.3% in patients with PPM <italic>versus</italic>
84.9&#x000b1;0.7% in patients without PPM (P&#x0003c;0.01). Additionally, our study showed no
statistically significant relationship between PPM and mortality
(<italic>P</italic>=0.12).</p><p>Several studies have shown a significant association between PPM and mortality<sup>[<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B16" ref-type="bibr">16</xref>]</sup>. A study demonstrated a correlation between
the valve index and mortality: a higher mortality rate was associated with a lower valve
index. In addition, the 8-year survival rates were 41%, 65%, and 74% when the valve index
was &#x0003c;0.60 cm<sup>2</sup>/m<sup>2</sup>, between 0.60 and 0.85
cm<sup>2</sup>/m<sup>2</sup>, and &#x0003c;0.85 cm<sup>2</sup>/m<sup>2</sup>,
respectively<sup>[<xref rid="B4" ref-type="bibr">4</xref>]</sup>.</p><p>Similar to our study, Howell et al.<sup>[<xref rid="B21" ref-type="bibr">21</xref>]</sup>
showed no significant association between PPM and mortality in two different studies. In the
prospective study of 1,481 patients with or without CABG, the 5-year survival was similar in
the PPM and non-PPM groups (83% <italic>vs.</italic> 81%, respectively,
<italic>P</italic>=0.47). In another study of 801 patients who underwent isolated aortic
valve replacement, PPM was not an independent mortality risk factor in either the short- or
long-term for moderate (<italic>P</italic>=0.4; HR 1.12) or severe (<italic>P</italic>=0.92;
HR 0.94) PPM<sup>[<xref rid="B16" ref-type="bibr">16</xref>]</sup>.</p><p>In a multivariate analysis of mortality predictors in patients undergoing aortic valve
replacement surgery, He et al.<sup>[<xref rid="B11" ref-type="bibr">11</xref>]</sup>
concluded that older age (<italic>P</italic>=0.0061; HR 1.0258) and concomitant CABG
(<italic>P</italic>=0.0115; HR 1.7146) were independent risk factors that affected
long-term survival. They observed a 10-year survival rate of 71% for valve replacement
without CABG and 40% when valve replacement was associated with this procedure
(<italic>P</italic>=0.02). In a Cox regression, Howell et al.<sup>[<xref rid="B21" ref-type="bibr">21</xref>]</sup> identified age as the only significant predictor of mortality
(<italic>P</italic>=0.004; RR 2.13). In another study by Howell et al.<sup>[<xref rid="B16" ref-type="bibr">16</xref>]</sup>, only the EuroSCORE findings were a
significant short- and long-term independent risk factor.</p><p>Those previous data are comparable to our study, in which the univariate analysis showed
that preoperative EF (<italic>P</italic>=0.02; HR 0.01) and EuroSCORE II results
(P=0.00000042; HR 1.13) were significant predictors of mortality, and the multivariate
analysis showed that age (<italic>P</italic>=0.01, HR 1.04) and concomitant surgery
(<italic>P</italic>=0.01, HR 5.04) were significant independent predictors of
mortality.</p><p>Because of limited control in obtaining the patient sample, only patients who underwent
outpatient monitoring at the study institution were included. Therefore, this study
represents the experience of a single institution and cannot be generalized to all patients
with a small aortic annulus. In addition, the surgical procedures were performed by
different surgeons with various levels of experience.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Implantation of a 19- or 21-mm bioprosthesis in patients undergoing aortic valve
replacement is a safe procedure. A valve index &#x0003c; 0.75 cm<sup>2</sup>/m<sup>2</sup> was
found in 16.83% of the patients, but it was not significantly associated with increased mean
aortic valve gradient in either the short or long-term nor was it associated with a higher
mortality in either the short or long term. Concomitant surgery, age, EF, and EuroSCORE II
findings were the main mortality predictors and significantly affected short-term survival.
After 6 months of follow-up, no differences were observed in the survival rates.</p><table-wrap id="t5" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors&#x02019; roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">JLRO</td><td align="left" rowspan="1" colspan="1">Conception and study design; execution of operations and/or trials;
analysis and/or data interpretation; statistical analysis; manuscript writing or
critical review of its content; final manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">RA</td><td align="left" rowspan="1" colspan="1">Execution of operations and/or trials; analysis and/or data
interpretation; manuscript writing or critical review of its content; final
manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">MAS</td><td align="left" rowspan="1" colspan="1">Execution of operations and/or trials; analysis and/or data
interpretation; manuscript writing or critical review of its content; final
manuscript approval;</td></tr><tr><td align="left" rowspan="1" colspan="1">AFSA</td><td align="left" rowspan="1" colspan="1">Execution of operations and/or trials; final manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">MI</td><td align="left" rowspan="1" colspan="1">Execution of operations and/or trials; final manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">Execution of operations and/or trials; final manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">PC</td><td align="left" rowspan="1" colspan="1">Execution of operations and/or trials; final manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">LCBS</td><td align="left" rowspan="1" colspan="1">Execution of operations and/or trials; final manuscript approval</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn><fn fn-type="other"><p>This study was carried out at Instituto Dante Pazzanese de Cardiologia, S&#x000e3;o Paulo,
SP, Brazil.</p></fn><fn fn-type="supported-by"><p>No financial support.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Paulis</surname><given-names>R</given-names></name><name><surname>Sommariva</surname><given-names>L</given-names></name><name><surname>Colagrande</surname><given-names>L</given-names></name><name><surname>De Matteis</surname><given-names>GM</given-names></name><name><surname>Fratini</surname><given-names>S</given-names></name><name><surname>Tomai</surname><given-names>F</given-names></name><etal/></person-group><article-title>Regression of left ventricular Hypertrophy after aortic valve replacement
for aortic stenosis with different valve substitutes</article-title><source>J Thorac Cardiovasc Surg</source><year>1998</year><volume>116</volume><issue>4</issue><fpage>590</fpage><lpage>598</lpage><pub-id pub-id-type="pmid">9766587</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahimtoola</surname><given-names>SH</given-names></name></person-group><article-title>The problem of valve prosthesis-patient mismatch</article-title><source>Circulation</source><year>1978</year><volume>58</volume><issue>1</issue><fpage>20</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">348341</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>V</given-names></name><name><surname>Jamieson</surname><given-names>WR</given-names></name><name><surname>Ivanov</surname><given-names>J</given-names></name><name><surname>Armstrong</surname><given-names>S</given-names></name><name><surname>David</surname><given-names>TE</given-names></name></person-group><article-title>Prosthesis-patient mismatch affects survival after aortic valve
replacement</article-title><source>Circulation</source><year>2000</year><volume>102</volume><issue>19</issue><supplement>Suppl 3</supplement><fpage>III</fpage><lpage>5-9</lpage></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohty</surname><given-names>D</given-names></name><name><surname>Malouf</surname><given-names>JF</given-names></name><name><surname>Girard</surname><given-names>SE</given-names></name><name><surname>Schaff</surname><given-names>HV</given-names></name><name><surname>Grill</surname><given-names>DE</given-names></name><name><surname>Enriquez-Sarano</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Impact of prosthesis-patient mismatch on long-term survival in patients
with small St Jude Medical mechanical prostheses in the aortic position</article-title><source>Circulation</source><year>2006</year><volume>113</volume><issue>3</issue><fpage>420</fpage><lpage>426</lpage><pub-id pub-id-type="pmid">16415379</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dotta</surname><given-names>F</given-names></name><name><surname>Torres</surname><given-names>M</given-names></name><name><surname>Manfroi</surname><given-names>W</given-names></name><name><surname>Guaragna</surname><given-names>J</given-names></name><name><surname>Caramoni</surname><given-names>P</given-names></name><name><surname>Albuquerque</surname><given-names>LC</given-names></name><etal/></person-group><article-title>Despropor&#x000e7;&#x000e3;o pr&#x000f3;tese a&#x000f3;rtica-paciente;
defini&#x000e7;&#x000e3;o, impacto e preven&#x000e7;&#x000e3;o</article-title><source>Rev Bras Ecocardiogr</source><year>2007</year><volume>20</volume><issue>4</issue><fpage>34</fpage><lpage>38</lpage></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Cao</surname><given-names>G</given-names></name><etal/></person-group><article-title>Impact of obesity on long-term survival after aortic valve replacement with
a small prosthesis</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2013</year><volume>17</volume><issue>1</issue><fpage>66</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">23529754</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shrestha</surname><given-names>M</given-names></name><name><surname>Maeding</surname><given-names>I</given-names></name><name><surname>H&#x000f6;ffer</surname><given-names>K</given-names></name><name><surname>Koigeldiyev</surname><given-names>N</given-names></name><name><surname>Marsch</surname><given-names>G</given-names></name><name><surname>Siemeni</surname><given-names>T</given-names></name><etal/></person-group><article-title>Aortic valve replacement in geriatric patients with small aortic root are
sutureless valves the future?</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2013</year><volume>17</volume><issue>5</issue><fpage>778</fpage><lpage>782</lpage><pub-id pub-id-type="pmid">23851988</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnoni</surname><given-names>RT</given-names></name><name><surname>Arnoni</surname><given-names>AS</given-names></name><name><surname>Meneghelo</surname><given-names>ZM</given-names></name><name><surname>Barroso</surname><given-names>CMQ</given-names></name><name><surname>Almeida</surname><given-names>AFS</given-names></name><name><surname>Abdulmassih</surname><given-names>C</given-names><suffix>Neto</suffix></name><etal/></person-group><article-title>Evolu&#x000e7;&#x000e3;o tardia de pacientes com pr&#x000f3;tese
a&#x000f3;rtica pequena (19 e 21 mm)</article-title><source>Rev Bras Cir Cardiovasc</source><year>1999</year><volume>14</volume><issue>4</issue><fpage>279</fpage><lpage>284</lpage></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sommer</surname><given-names>KE</given-names></name><name><surname>David</surname><given-names>TE</given-names></name></person-group><article-title>Aortic valve replacement with patch enlargement of the aortic
annulus</article-title><source>Ann Thorac Surg</source><year>1997</year><volume>63</volume><issue>6</issue><fpage>1608</fpage><lpage>1612</lpage><pub-id pub-id-type="pmid">9205157</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deucher</surname><given-names>Z</given-names><suffix>Junior</suffix></name><name><surname>Bastos</surname><given-names>ES</given-names></name><name><surname>Feitosa</surname><given-names>JLA</given-names></name><name><surname>Giambroni</surname><given-names>R</given-names><suffix>Filho</suffix></name><name><surname>Azevedo</surname><given-names>JAP</given-names></name><name><surname>S&#x000e1;</surname><given-names>MPL</given-names></name><etal/></person-group><article-title>Gradiente residual em opera&#x000e7;&#x000e3;o de valva
a&#x000f3;rtica</article-title><source>Rev Bras Cir Cardiovasc</source><year>2000</year><volume>15</volume><issue>2</issue><fpage>136</fpage><lpage>142</lpage></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>GW</given-names></name><name><surname>Grunkemeier</surname><given-names>GL</given-names></name><name><surname>Gately</surname><given-names>HL</given-names></name><name><surname>Furnary</surname><given-names>AP</given-names></name><name><surname>Starr</surname><given-names>A</given-names></name></person-group><article-title>Up to thirty-year survival after aortic valve replacement in the small
aortic root</article-title><source>Ann Thorac Surg</source><year>1995</year><volume>59</volume><issue>5</issue><fpage>1056</fpage><lpage>1062</lpage><pub-id pub-id-type="pmid">7733698</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chalmers</surname><given-names>J</given-names></name><name><surname>Pullan</surname><given-names>M</given-names></name><name><surname>Fabri</surname><given-names>B</given-names></name><name><surname>McShane</surname><given-names>J</given-names></name><name><surname>Shaw</surname><given-names>M</given-names></name><name><surname>Mediratta</surname><given-names>N</given-names></name><etal/></person-group><article-title>Validation of EuroSCORE II in a modern cohort of patients undergoing
cardiac surgery</article-title><source>Eur J Cardiothorac Surg</source><year>2013</year><volume>43</volume><issue>4</issue><fpage>688</fpage><lpage>694</lpage><pub-id pub-id-type="pmid">22833541</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manouguian</surname><given-names>S</given-names></name><name><surname>Seybold-Epting</surname><given-names>W</given-names></name></person-group><article-title>Patch enlargement of the aortic valve ring by extending the aortic incision
into the anterior mitral leaflet New operative technique</article-title><source>J Thorac Cardiovasc Surg</source><year>1979</year><volume>78</volume><issue>3</issue><fpage>402</fpage><lpage>412</lpage><pub-id pub-id-type="pmid">470420</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilbring</surname><given-names>M</given-names></name><name><surname>Alexiou</surname><given-names>K</given-names></name><name><surname>Schumann</surname><given-names>E</given-names></name><name><surname>Matschke</surname><given-names>K</given-names></name><name><surname>Tugtekin</surname><given-names>SM</given-names></name></person-group><article-title>Isolated aortic valve replacement in patients with small aortic annulus-a
high-risk group on long-term follow-up</article-title><source>Thorac Cardiovasc Surg</source><year>2013</year><volume>61</volume><issue>5</issue><fpage>379</fpage><lpage>385</lpage><pub-id pub-id-type="pmid">23258763</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulik</surname><given-names>A</given-names></name><name><surname>Al-Saigh</surname><given-names>M</given-names></name><name><surname>Chan</surname><given-names>V</given-names></name><name><surname>Masters</surname><given-names>RG</given-names></name><name><surname>B&#x000e9;dard</surname><given-names>P</given-names></name><name><surname>Lam</surname><given-names>BK</given-names></name><etal/></person-group><article-title>Enlargement of the small aortic root during aortic valve replacement is
there a benefit?</article-title><source>Ann Thorac Surg</source><year>2008</year><volume>85</volume><issue>1</issue><fpage>94</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">18154789</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howell</surname><given-names>NJ</given-names></name><name><surname>Keogh</surname><given-names>BE</given-names></name><name><surname>Ray</surname><given-names>D</given-names></name><name><surname>Bonser</surname><given-names>RS</given-names></name><name><surname>Graham</surname><given-names>TR</given-names></name><name><surname>Mascaro</surname><given-names>J</given-names></name><etal/></person-group><article-title>Patient-prosthesis mismatch in patients with aortic stenosis undergoing
isolated aortic valve replacement does not affect survival</article-title><source>Ann Thorac Surg</source><year>2010</year><volume>89</volume><issue>1</issue><fpage>60</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">20103206</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahlmann</surname><given-names>E</given-names></name><name><surname>Cramariuc</surname><given-names>D</given-names></name><name><surname>Minners</surname><given-names>J</given-names></name><name><surname>Lonnebakken</surname><given-names>MT</given-names></name><name><surname>Ray</surname><given-names>S</given-names></name><name><surname>Gohlke-Baerwolf</surname><given-names>C</given-names></name><etal/></person-group><article-title>Prognostic implications of small aortic root in aortic valve
stenosis</article-title><source>Circulation</source><year>2014</year><volume>130</volume><fpage>A9397</fpage><lpage>A9397</lpage></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walther</surname><given-names>T</given-names></name><name><surname>Rastan</surname><given-names>A</given-names></name><name><surname>Falk</surname><given-names>V</given-names></name><name><surname>Lehmann</surname><given-names>S</given-names></name><name><surname>Garbade</surname><given-names>J</given-names></name><name><surname>Funkat</surname><given-names>AK</given-names></name><etal/></person-group><article-title>Patient prosthesis mismatch affects short- and long-term outcomes after
aortic valve replacement</article-title><source>Eur J Cardiothorac Surg</source><year>2006</year><volume>30</volume><issue>1</issue><fpage>15</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">16730449</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takaseya</surname><given-names>T</given-names></name><name><surname>Kawara</surname><given-names>T</given-names></name><name><surname>Tokunaga</surname><given-names>S</given-names></name><name><surname>Kohno</surname><given-names>M</given-names></name><name><surname>Oishi</surname><given-names>Y</given-names></name><name><surname>Morita</surname><given-names>S</given-names></name></person-group><article-title>Aortic valve replacement with 17-mm St Jude Medical prostheses for a small
aortic root in elderly patients</article-title><source>Ann Thorac Surg</source><year>2007</year><volume>83</volume><issue>6</issue><fpage>2050</fpage><lpage>2053</lpage><pub-id pub-id-type="pmid">17532394</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>V</given-names></name><name><surname>Christakis</surname><given-names>GT</given-names></name><name><surname>Sever</surname><given-names>J</given-names></name><name><surname>Fremes</surname><given-names>SE</given-names></name><name><surname>Bhatnagar</surname><given-names>G</given-names></name><name><surname>Cohen</surname><given-names>G</given-names></name><etal/></person-group><article-title>A novel comparison of stentless versus stented valves in the small aortic
root</article-title><source>J Thorac Cardiovasc Surg</source><year>1999</year><volume>117</volume><issue>3</issue><fpage>431</fpage><lpage>436</lpage><pub-id pub-id-type="pmid">10047644</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howel</surname><given-names>NJ</given-names></name><name><surname>Keogh</surname><given-names>BE</given-names></name><name><surname>Barnet</surname><given-names>V</given-names></name><name><surname>Bonser</surname><given-names>RS</given-names></name><name><surname>Graham</surname><given-names>TR</given-names></name><name><surname>Rooney</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Patient-prosthesis mismatch does not affect survival following aortic valve
replacement</article-title><source>Eur J Cardiothorac Surg</source><year>2006</year><volume>30</volume><issue>1</issue><fpage>10</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">16723251</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vohra</surname><given-names>HA</given-names></name><name><surname>Whistance</surname><given-names>RN</given-names></name><name><surname>Bolgeri</surname><given-names>M</given-names></name><name><surname>Velissaris</surname><given-names>T</given-names></name><name><surname>Tsang</surname><given-names>GM</given-names></name><name><surname>Barlow</surname><given-names>CW</given-names></name><etal/></person-group><article-title>Mid-term evaluation of Sorin Soprano bioprotheses in patients with a small
aortic annulus &#x00026;lt;or=20 mm</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2010</year><volume>10</volume><issue>3</issue><fpage>399</fpage><lpage>402</lpage><pub-id pub-id-type="pmid">19952015</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celiento</surname><given-names>M</given-names></name><name><surname>Saccocci</surname><given-names>M</given-names></name><name><surname>De Martino</surname><given-names>A</given-names></name><name><surname>Nardi</surname><given-names>C</given-names></name><name><surname>Faggioni</surname><given-names>L</given-names></name><name><surname>Milano</surname><given-names>AD</given-names></name><etal/></person-group><article-title>Stability of aortic annulus enlargement during aortic valve replacement
using a bovine pericardial patch an 18-year clinical, echocardiographic, and
angio-computed tomographic follow-up</article-title><source>J Thorac Cardiovasc Surg</source><year>2014</year><volume>147</volume><issue>3</issue><fpage>977</fpage><lpage>983</lpage><pub-id pub-id-type="pmid">23540656</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Bacco</surname><given-names>MW</given-names></name><name><surname>Sartori</surname><given-names>AP</given-names></name><name><surname>Sant'Anna</surname><given-names>JRM</given-names></name><name><surname>Santos</surname><given-names>MF</given-names></name><name><surname>Prates</surname><given-names>PR</given-names></name><name><surname>Kalil</surname><given-names>RAK</given-names></name><etal/></person-group><article-title>Fatores de risco para mortalidade hospitalar no implante de pr&#x000f3;tese
valvar mec&#x000e2;nica</article-title><source>Rev Bras Cir Cardiovasc</source><year>2009</year><volume>24</volume><issue>3</issue><fpage>334</fpage><lpage>340</lpage><pub-id pub-id-type="pmid">20011880</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tagliari</surname><given-names>AP</given-names></name><name><surname>Pivatto</surname><given-names>F</given-names><suffix>Junior</suffix></name><name><surname>Valle</surname><given-names>FH</given-names></name><name><surname>Sannt'Anna</surname><given-names>JRM</given-names></name><name><surname>Prates</surname><given-names>PR</given-names></name><name><surname>Nesralla</surname><given-names>IA</given-names></name><etal/></person-group><article-title>Resultados da cirurgia por estenose a&#x000f3;rtica em pacientes acima de 75
anos em 4 5 anos de seguimento</article-title><source>Rev Bras Cir Cardiovasc</source><year>2012</year><volume>27</volume><issue>2</issue><fpage>267</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">22996978</pub-id></element-citation></ref></ref-list></back></article>